The factors involved in the control of steroid secretion from the ovine placenta and in fetal growth are as yet unclear. We hypothesized that factors derived from the fetal pituitary may play a role in the production and release of placental steroids and in growth of the fetus, and have investigated the effects of fetal hypophysectomy performed between day 70 and day 79 of gestation (term = 147 days) on systemic concentrations of hormones derived from the placenta, and on fetal growth. Maternal peripheral progesterone, placental lactogen and uterine vein progesterone increased significantly from day 90 in all ewes. Peripheral concentrations of prostaglandin E2 and peripheral and uterine vein oestrone sulfate increased significantly in the control group but not in the fetal hypophysectomy group. Uterine vein prostaglandin E2 increased significantly after day 95 in the control group and after day 105 in the fetal hypophysectomy group. Early fetal hypophysectomy caused marked growth retardation. The weights of the brain, kidneys and liver of hypophysectomized fetuses were the same as those of controls suggesting that their growth is not under pituitary control. In contrast, the weights of heart and lungs were reduced in proportion to body weight, suggesting that heart, lung and carcass growth were under pituitary control. Our data indicate that the fetal pituitary influences the control of placental steroid and prostaglandin E2 biosynthesis after day 90 of gestation in sheep, but that output of other hormones such as placental lactogen is independent of pituitary control, and may determine organ-specific growth parameters that are unaffected by removal of the fetal pituitary.
Introduction
The placental production of oestrogens, as judged by the urinary excretion of 17a-oestradiol and oestrone in pregnant ewes (Fevre and Rombauts, 1966; Fevre, 1967 ) commences at about day 70 and increases rapidly between days 90 and 120 of gestation. A similar temporal pattern was observed in the oes¬ trogen sulfoconjugates in fetal (Findlay and Cox, 1970; Findlay and Seamark, 1973) and maternal (Tsang, 1974; Carnegie and Robertson, 1978) plasma. Kendall et al (1977) reported that when synthetic ACTH1J4 (Synacthen: Ciba Laboratories Limited) was infused into sheep fetuses, hypophysectomized between days 110 and 120 of gestation, the preparturient oestrogen surge was not seen. They suggested that an intact fetal pituitary gland is required for the increase in the concentrations of unconjugated oestrogens in maternal plasma prepartum, although the nature of the fetal pituitary factor was unknown (except that they suggested that it did not reside in the 1-24 fraction of the ACTH molecule). In contrast, Ricketts et al (1980) found that fetal hypophysectomy failed to block the preparturient rise in oestradiol in response to the infusion of Synacthen; however, they found that fetal hypophysectomy reduced the normal rise in oestrone sulfate, abolished the normal rise in androstenedione concentrations and reduced placental activities of C-17,20 lyase and aromatase. These fetuses were hypophysectomized between 119 and 130 days gestation. Fetal hypophysectomy between days 110 and 124 of ges¬ tation produced no significant change in the concentrations of unconjugated oestradiol and progesterone in the plasma of ewes carrying these fetuses (Kendall et al, 1977; Robinson et al, 1977; Ricketts et al, 1980) . Thus it has been concluded that the production of steroids by the ovine placenta is independent of fetal pituitary control and that placental progesterone produc¬ tion is autonomous. The studies on which these conclusions were based were performed after the major increase in steroid concentrations that occurs around day 90 of gestation. It therefore seemed possible that the lack of effect of fetal hypo¬ physectomy in sheep was due to the hypophysectomy being performed too late. To test this hypothesis it was decided to hypophysectomize fetal lambs at about day 70 of gestation (term = 147 days) before the major increase in the progester¬ one concentrations in maternal plasma which occurs at about 80-90 days gestation in the sheep (Bassett et al, 1969) .
Our earlier data in which fetal lambs were hypophysectom¬ ized at 116 days of gestation (Mesiano et al, 1987) produced changes in the appendicular skeleton and organs shown to be pituitary dependent but other organs were affected; we there¬ fore decided to examine the effects of a longer period of pituitary deprivation.
Materials and Methods

Animals
Fourteen pregnant Border-Leicester x Merino ewes of known gestational age were used over the two years of this study. Trans-sphenoidal hypophysectomy was carried out aseptically on 13 fetuses (eight ewes; three singletons, five twins) between 70 and 80 days of gestation. Anaesthesia was induced with 1 g thiopentone sodium in water (intravenously) and was maintained after trachéal intubation with 1.5% halothane (oxygen:nitrous oxide, 50:50 vol:vol). In the case of twins, both fetuses were hypophysectomized or both were shamoperated. The fetal head was exposed through a maternal hysterotomy and held in extension with the ventral surface uppermost. The skin was incised in the midline in the area of the basihyoid bone and blunt dissection was used to ap¬ proach the basisphenoid bone. This bone was then drilled through in the midline with a 3 mm diamond burr under 10 magnification, exposing the dura overlying the pitu¬ itary. The dura was then opened in the midline and micro¬ scopic dissection was used to free the pituitary from its coverings. The pituitary was then aspirated with a suction instrument (5 French gauge) and the sella turcica was packed with gelatin sponge (Gelfoam: The Upjohn Company, Kalamazoo, Michigan). The fetal skin was closed with 6-0 catgut or polypropylene suture. Sham operations were per¬ formed on ten fetuses (six ewes; two singletons, four twins) between 70 and 82 days of gestation. In this case, the soft tissue dissection was carried out to display the basisphenoid bone but no drilling was performed. All ewes were ovariecto¬ mized during surgery (to remove the ovarian component of progesterone) and vascular catheters were inserted into a maternal carotid artery, jugular vein and uterine vein.
Three of the hypophysectomized fetuses (two ewes) under¬ went surgery again at 116 days of gestation to insert vascular catheters into the fetal carotid artery and jugular vein. The fetal and uterine vein catheters were exteriorized via an incision in the ewe's flank. All catheters were filled with sterile heparinized saline (0.9% NaCl; 50 000 iu heparin 1). After surgery, the ewes were housed in metabolic cages and fed once daily. Water was provided ad libitum. The uterine vein cannulae were there¬ after continuously infused with heparinized saline using in¬ fusion pumps (Braun Perfusor Secura: . Braun Melsungen AG, Melsungen, Germany) at a rate of 0.6 ml h_1.
All ewes and fetuses were killed by an overdose of barbitu¬ rate (Lethabarb: Arnolds of Reading Pty Ltd, Boronia, Victoria). Completeness of hypophysectomy was assessed by examining the sella turcica for remnants of pituitary tissue and the weights of adrenal and thyroid glands were carefully noted. The degree of wool development, a sensitive index of thyroid function (Hopkins and Thorburn, 1972) , was also noted. Other fetal organs (liver, kidneys, heart, lungs and brain) were removed at autopsy and weighed. Six ewes (eight fetuses) were killed between day 144 and day 146 of gestation. One control ewe delivered live twins before this time (143 days) and three ewes were killed at day 127 of gestation. Two of the ewes carrying hypophysectomized fetuses were allowed to continue pregnancy until day 155 of gestation before they were killed.
Sample collection
The gestational profile of the relevant hormones was exam¬ ined by collecting maternal peripheral, carotid artery or jugular vein (20-25 ml), and uterine vein (20 ml) blood samples at 5 day intervals from 75 to 140 days of gestation, and then daily from 141 to 145 days of gestation. In most instances, peripheral samples taken were arterial, but if this catheter was blocked, jugular vein samples were collected (there was no statistical difference between sampling sites). Fetal arterial samples (10 ml) were taken from the three re-operated fetuses between 120 and 129 days of gestation. Blood was collected between 08:00 h and 10:00 h on the day of sampling, before the ewes were fed.
Blood samples for progesterone, oestrone sulfate and pla¬ cental lactogen estimation were collected into chilled tubes containing 125 iu lithium heparin (Johns Division Mallinkrodt (Australia) Pty Ltd, South Oakleigh, Victoria) and centrifuged for 10 min at 2000 # at 4°C. The separated plasma was stored at -20°C.
Blood for prostaglandin E2 measurement was collected into chilled tubes containing 15 mg EDTA and indomethacin (final concentration 10 pmol 1~!) and centrifuged for 10 min at 2000 # at 4°C. The plasma was diluted 1:1 with 0.12 mol methoxyamine hydrochloride 1_1 (Sigma Chemical Company, St Louis, MO) in sodium acetate buffer (1 mol 1~\ pH5.6) containing 10% absolute ethanol and incubated overnight at room temperature before storage at -20°C.
Progesterone assay
Peripheral and uterine vein plasma concentrations of pro¬ gesterone were measured as described by Rice et al (1986) with modifications. Aliquots (50 µ ) of plasma were extracted with 2.0 ml «-hexane (Mallinckrodt (Australia) Pty Ltd, Clayton, Victoria). Phosphate buffer (0.1 mol l-1, pH 7.0) was used as diluent and [l,2,6,7-3H(N)]-progesterone (4218 GBq mmol'1) was obtained from DuPont NEN Products (Boston). The antiserum (S23; 1:2500 final dilution), raised against progesterone-11-Ct-BSA in sheep, was provided by J. Malecki (Regional Veterinary Institute, Department of Agricultural and Rural Affairs, Baimsdale, Victoria). The crossreaction of this antiserum was 100% with progesterone, 43.8% with lla-hydroxyprogesterone, 2.4% with pregnenolone, <1.0% with 5ßpregnan-3ß-ol-20-one or dehydroepiandrosterone, <0.3% with 20ct-hydroxy-4-pregnen-3-one and < 2.0% with Cortisol. Antibody-bound and free steroid were separated by adding 50 µ normal human immunoglobulin (20 mg ml-1; Common¬ wealth Serum Laboratories, Melbourne) and 1 ml polyethylene glycol (PEG) 6000 (27%; BDH Chemicals, Kilsyth, Victoria). The tubes were then centrifuged at 2500# for 15 min at 4°C The supernatant was aspirated and the pellet dissolved in dis¬ tilled H20 (50 µ ). Tubes were sonicated for 30 min after adding 1.8 ml scintillation fluid (ACS: Amersham Corporation, Arlington Heights, IL) and the radioactivity measured in a liquid scintillation counter (LS5000TA: Beckman Instruments Inc., Scientific Instruments Division, Fullerton, CA). The intra-and interassay coefficients of variation, estimated from 14 assays were 10.0 and 16.2%, respectively. The sensitivity of the assay was 2.91 ± 0.41 nmol 1 (mean ± SEM).
Prostaglandin E2 assay
Peripheral and uterine vein plasma concentrations of prosta¬ glandin E2 (PGE2) were measured as described by Fowden et al (1987) . Labelled PGE2, [5,6,8,ll,12,14,15-3H(N) ]-prostaglandin E2 (DuPont NEN Products, Boston, MA; 6845 GBq mmol"1), and standard PGE2 (0.5 mg; Sigma, St Louis, MO) were methyl oximated as described by Fowden et al (1987) . The methyl oxime assay standards ranged from 0.02 to 1.2 pmol PGE2 per tube and plasma aliquots of 50-200 µ methyloximated samples were assayed in duplicate without extraction. Equiv¬ alent amounts of methyloximated plasma (treated with charcoal to remove steroids) were added to the standard curve. Antiserum, raised in goats against the methyl oxime of PGE2 conjugated to bovine serum albumin, was supplied by R. F. Seamark (Adelaide). This antiserum crossreacted 100% with PGE2 methyloxime, 270% with PGEr 0.3% with 15-keto-PGE2, 0.1% with 13,14-dihydro-15-keto-PGF2a and <0.01% with prostaglandins B2, D,, D2, F2a, F2ß, 6-keto-PGFIa, thromboxane B2, 15-keto-PGF2a and 13,14,dihydro-PGF20. The intra-assay coefficient of variation was 10.0% and the interassay coefficient of variation was 19.3% at 12.7 nmol l and 17.1% at 28.0 nmol 1, as estimated from 11 assays. The limit of sensitivity of the assay was 0.56 ± 0.10 nmol l"1 (mean ± SEM).
Placental lactogen assay
Peripheral plasma placental lactogen concentrations were assayed according to the method of Chan et al. (1978) as described by Rice and Thorburn (1986) . Standard (prepared by the method of Chan et al, 1978) and antiserum were provided by M. J. Waters (Department of Physiology, University of Queensland, Australia). This antiserum was raised against purified ovine placental lactogen (oPL) in goats and its crossreactivity with ovine pituitary hormones (growth hormone, luteinizing hormone, follicle-stimulating hormone, prolactin and thyroid stimulating hormone) was < 1%.
Oestrone sulfate assay
Peripheral and uterine vein plasma oestrone sulfate concen¬ trations were measured in duplicate aliquots of 20 µ of plasma using an antiserum raised in sheep (6944) Hoskinson (CSIRO Division of Animal Production, Prospect, NSW, Australia). The only steroids to crossreact significantly with this antiserum were oestrone sulfate (100%) and oestrone (120%). Carnegie and Robertson (1978) have shown that oes¬ trone sulfate is the predominant oestrogen present in both fetal and maternal fluids throughout gestation in the ewe but this assay probably measures a proportion of oestrone as well as its sulfate. Aliquots (20 µ ) of charcoal-stripped maternal sheep plasma were added to known amounts (0.006-1.63 pmol per tube) of the standard oestrone sulfate (Sigma Chemical Co., St Louis, MO), before the volume in all tubes was made up to 0.1 ml with assay buffer (0.1 mol sodium phosphate buffer I , pH 7.0, containing 0.9% sodium chloride, 0.1% sodium azide and 0.1% gelatine). Standards and plasma samples were incubated at 4°C for a minimum of 1 h with 0.1 ml tracer [6,7-3H(N)]-oestrone sulfate, ammonium salt (DuPont NEN Products, Boston, MA; 2220 GBq mmol"!) and 0.1 ml antiserum (1:39 000 final dilution) in assay buffer. Antibody-bound oestrone sulfate was precipi¬ tated with PEG 6000, as described for the progesterone radioimmunoassay. Scintillant (1.5 ml; Scintisol: Isolab, OH) was added prior to counting in a liquid scintillation counter (LS5000TA: Beckman Instruments Inc., Scientific Instruments Division, Fullerton, CA). The interassay coefficient of variation was 27% at 2.49 nmol 1 and 17.4% at 27.9 nmol l"1, esti¬ mated from 14 assays. The limit of sensitivity of the assay was 0.02 pmol per tube.
Statistical analysis
The following analyses were carried out using a program for statistical data analysis (SPSS-X). Body dimensions and organ weights were analysed by t tests, using the appropriate pooled or separate variance estimate. In analysing uterine vein hormone concentrations, samples from ewes carrying single¬ tons were from the pregnant horn only, whereas for twin preg¬ nancies, simultaneous samples were taken from both uterine veins and concentrations were averaged for further analysis. Hormone concentrations were first tested for homogeneity of variance using Bartlett-Box F and Cochran's C test. Where hormone concentrations were found not to be homogeneous, a square root transformation was used to render these homo¬ geneous. Concentrations were then analysed using a repeated measures analysis of variance (ANOVA), fitting polynomial functions in gestational age to the values obtained. Treatment, gestational age and individual animal were used as factors in this analysis to identify any changes in maternal hormone con¬ centrations over the gestational period studied and any effect of fetal hypophysectomy.
Results
Fetal outcome
Fetal outcome is summarized (Table 1 ). Initially we had planned to re-operate on all hypophysectomized fetuses at day 116 of gestation and insert vascular catheters to collect blood samples for hormone assay and assessment of fetal well-being by measuring fetal blood gases using an ABL 30 acid base analyser and OSM2 hemoximeter (Radiometer, Copenhagen).
The second operation resulted in the death of two of the three fetuses within one week and these two ewes (1046, 8086) were killed at 124-129 days of gestation following the rapid deterio¬ ration in the fetal blood gases. In subsequent experiments, hypophysectomized fetuses were not catheterized. The samples collected from the three catheterized fetuses were not assayed.
Owing to the difficulty in maintaining the patency of cath¬ eters and therefore the data being incomplete after 125 days of gestation, we have only included in the analysis blood samples collected from all animals between days 75 and 125 of gestation. From examination of the fetuses at autopsy, it was concluded that those fetuses that had died in utero would have been dead for only one or two days. Consequently the samples analysed to day 125 would have been unaffected. bReoperated fetuses (insertion of vascular catheters).
cFetuses included in size and weight analyses (Tables 2 and 3 ).
Fetal body and organ weights
The measurements taken (Tables 2 and 3 ) were from only those fetuses alive at the time of maternal death and between the gestational ages of 144 and 146 days. Animals outside this range were not included. Hypophysectomized fetuses appeared to have abundant subcutaneous fat, short legs relative to body length and very little wool growth at term (147 days of gestation) compared with sham-operated fetuses. Although hypophysectomized fetuses were generally smaller than shamoperated fetuses, not all body size parameters were uniformly reduced as a proportion of body length or weight (Table 3) . The limbs and thyroid glands were disproportionately small, whereas the kidneys and brains were significantly heavier in the hypophysectomized group when expressed as a proportion of body weight.
Hormone concentrations
Progesterone. After day 95 of gestation, maternal peripheral progesterone concentrations increased in both treatment groups (P < 0.001); this increase was greater in the control group. There was no difference between the two treatment groups from day 75 to day 95 of gestation (13.2 + 1.15 nmol 1" ). In ewes carrying sham-operated fetuses, progesterone con¬ centrations increased from 14.5 nmol l"1 at day 95 to 46.8 nmol Iat day 125 of gestation. In ewes carrying hypophysectom¬ ized fetuses, peripheral progesterone concentrations increased from 16.8 nmol 3 at day 95 to 27.4 nmol 1 at day 125 of gestation (Fig. 1 ). Progesterone concentrations in the uterine vein increased (P < 0.001) in both groups of ewes (hypophys¬ ectomy and control) from 51.7 + 11.5 nmol l"1 at day 75 to 121.9 + 15.9 nmol l"1 at day 125 of gestation; there was no difference between the two treatment groups.
Prostaglandin E2. PGE2 concentrations were not different between the two treatment groups from day 75 to day 95 of gestation in either peripheral (1.90 + 0.23 nmol l"1) or uterine vein plasma (1.90 + 0.32 nmol l"1). Peripheral plasma PGE2 concentrations in control ewes increased (P < 0.001) after day 95 to exceed 11.7 nmol 1" by day 125 of gestation, whereas concentrations in ewes carrying hypophysectomized fetuses did not change, but remained at about 1.59 + 0.16 nmol 1_I, throughout the gestational period studied (Fig. 2) . Uterine vein plasma PGE2 concentrations also increased (P < 0.001) in control ewes after day 95 to exceed 13.5 nmol l"1 by day 125. (Fig. 3 ). Uterine vein oestrone sulfate concentrations in control ewes also increased (P < 0.001) from 0.91 nmol l"1 at day 80 to 6.95 nmol 1_1 at day 125 of gestation. In ewes carrying hypophysectomized fetuses, oestrone sulfate concen¬ trations did not change from day 80 to day 125 of gestation in either peripheral (remaining at 1.98 + 0.17 nmol l"1) or uterine vein plasma (remaining at 1.50 + 0.19 nmol l-).
Placental lactogen. Placental lactogen was measured only in blood sampled from maternal peripheral catheters.
Concentrations increased in all ewes (P < 0.001) from 7.18 + 4.16 nmol 1 at day 75 to 49.6 + 9.51 nmol 1 at day 125 of gestation.
Discussion
Fetal hypophysectomy at days 70-80 of gestation decreased maternal plasma concentrations of progesterone between day 95 and day 125 compared with sham-operated controls, but progesterone concentrations increased in both groups after day 95 of gestation. This suggests that the fetal pituitary does have some influence on placental progesterone production. The nature of the pituitary trophic factor is unknown. This study has confirmed earlier observations of a parallel increase in the maternal plasma concentrations of progesterone and ovine placental lactogen (oPL) (Chan et al, 1978; Taylor et al, 1983) . The reason for this association is unknown. Studies with human trophoblast explants (Handwerger et al, 1987) and cells (Sane el al, 1988) showed that high density lipoproteins (HDL) stimulated the release of human placental lactogen and that the active components were the apoproteins of HDL.
Recently Grandis et al (1989) have also shown in sheep that ovine HDL, but not lipoprotein-free plasma proteins, stimulate the secretion of oPL in pregnant ewes. Liggins and Thorburn (in press) have proposed that the uptake of HDL by the ovine placenta provides cholesterol for progesterone synthesis, arachidonic acid as a precursor for PGE2 synthesis and provides a stimulus for oPL release. Thus the uptake of HDL by the ovine placenta between 90 and 125 days of gestation may explain the parallel increase in the plasma concentrations of progesterone, PGE2 and oPL.
In contrast to the findings with progesterone, fetal hypo¬ physectomy abolished the increase in maternal plasma con¬ centrations of oestrone sulfate between days 90 and 125 of gestation. The source of the precursors for placental oestrogen biosynthesis is a matter of debate. It is possible that the fetal adrenal gland secretes C-19 steroids which are readily con¬ verted by placental aromatase to oestrogens. Mitchell et al (1986) showed that 30% of maternal oestrogen is derived from androstenedione of fetal origin. Fetal hypophysectomy, by removing pituitary ACTH, would inhibit the secretion of C-19 steroids by the fetal adrenal gland and could explain the failure of placental oestrogen synthesis to increase in these exper¬ iments. Alternatively, despite extremely low concentrations of 17rx-hydroxylase in the placenta at that time (France et al, 1988; Mason el al, 1989) , the activity of this enzyme may be sufficient to metabolize small amounts of pregnenolone through the 5-pathway to oestrogens.
Fetal hypophysectomy also abolished the expected increase in placental PGE2 production during the last third of gestation; however, the concentration of prostaglandin in the uterine vein did increase from 110 days onwards. This discrepancy may be explained in part by a fall in uterine blood flow following fetal hypophysectomy. Earlier studies by our group have shown that the progressive increase in maternal arterial and uterine vein PGE2 concentrations (Fowden et al, 1987) parallel the increase in prostaglandin H synthase (PGHS) activity in the ovine placenta (Risbridger et al, 1985; Rice et al, 1988 Rice et al, , 1990 . Rice et al. (1990) have shown that fetal hypophysectomy inhibits this increase in placental PGHS activity, which suggests that the increase in PGE2 production by the ovine placenta is secondary to the increase in PGHS activity and that it is under the influence of the fetal pituitary. The immunohistochemical studies of Boshier et al (1991) indicate that during the last 30 days of gestation, PGHS is situated mainly in the fetal tropho¬ blast and that PGHS is not present in the binucleate cells, which are thought to form part of the maternal syncytium (Wooding, 1984) . Ralph (1991) , using cell cultures, has shown that the uninucleate cells of the trophoblast and the fibroblasts of the ovine placentome produce prostaglandins. Risbridger et al (1985) had earlier shown that placental (trophoblast) cells were the major site of prostaglandins during this time. These studies suggest that fetal pituitary hormones may regulate placental PGHS either directly or indirectly. It has been shown in the rat ovary (Clark et al, 1979 ) that LH can induce PGHS activity. LH from the fetal pituitary may therefore play a role in regulating placental PGHS (Thorbum et al, 1989) The present study extends our knowledge of the effects of hypophysectomy on growth of the fetus. We have previously reported the effects of hypophysectomy carried out at about 115 days, noting that the organs that are most severely growth retarded were the appendicular skeleton and adrenal glands (Mesiano et al, 1987) . The effects of a longer period of fetal pituitary deprivation reported here confirm our earlier data and extend the findings of earlier studies (Liggins and Kennedy, 1968; Parkes and Hill, 1985) . In addition, early hypophysec¬ tomy (days 70-80 of gestation) results in significant deficits in fetal head length, body weight, and heart, lung and thyroid weights which were not affected by hypophysectomy later in gestation. However, in the previous study (Mesiano et al, 1987) insufficient time may have elapsed between hypophysectomy and autopsy for these effects to attain statistical significance.
Examination of the standardized weights and dimensions (Table 3 ) reveals that the pattern of growth associated with early fetal hypophysectomy is similar to that of control fetuses except that the limbs are disproportionately short, thyroid weight is disproportionately reduced and brain, liver and kidney weights are relatively spared. These findings suggest that the growth of the brain, liver and kidney is regulated differently from that of most other organs. Indeed, the weights of the brain, liver and kidney of hypophysectomized fetuses at autopsy were the same as those of the controls. These results suggest that these organs grow in response to an extra-pituitary stimulus that may be independent of fetal pituitary control and could be oPL. Simi¬ larly, the increase in subcutaneous adipose tissue following hypophysectomy may result from removal of the lipolytic action of pituitary hormones (e.g. growth hormone) while the lipogenic action of oPL is maintained. If so, oPL receptors should be present in these tissues. In contrast, the weights of the heart and lungs were reduced in proportion to body weight, suggesting that the heart, lungs and carcass were under the control of the fetal pituitary. To our knowledge, this is the first report that the growth of the fetal heart and lungs may be under the influence of pituitary hormones, but the relative importance of the individual pituitary hormones and locally produced growth factors are not addressed by this study.
After hypophysectomy, the fetal limbs continue to grow. If the growth of the limbs between the time of surgery and autopsy (obtained by subtracting the values estimated from Cloete's (1939) growth data, i.e. forelimb length 9.0 cm, hindlimb length 10.0 cm from the observed values for hypophys¬ ectomized and sham-operated fetuses) is considered, then it appears that the limbs of hypophysectomized fetuses elongated by about 70% of the values obtained for the sham-operated controls. Interestingly, application of this method to the data generated by hypophysectomy later in gestation yields a simi¬ lar estimate of the proportion of limb growth that is pituitary dependent. This suggests that the mechanisms governing limb growth do not alter markedly after mid-gestation.
The relative contributions of the various pituitary hormones to somatic growth remain unclear. The present findings of reduced body weight, limb length and skin development are consistent with fetal hypothyroidism (Hopkins and Thorburn, 1972 ), although we were unable to ameliorate these deficiencies by thyroxine replacement in our previous study (Mesiano et al, 1987) . Although the hypophysectomized ovine fetus is practi¬ cally athyroid (Thorbum and Hopkins, 1973) , the present study failed to reproduce the retardation of brain growth noted by Bhakthavathsalan et al (1977) after fetal thyroidectomy carried out at 104-111 days of gestation.
In conclusion, our results suggest that the fetal pituitary influences growth, placental steroidogenesis and prostaglandin production after day 90 of gestation in sheep. Further studies are required to determine which pituitary factors are involved.
